rg Reinhardt    B_AO1_R_N IH0_N 1956    HH_AE1_Z B_IH1_N Chairman AH1_V DH_AH0 Board AH1_V Directors AH1_V DH_AH0 Swiss F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L G_R_UW1_P Novartis AG S_IH1_N_S 2013     Since 2017    HH_IY1 HH_AE1_Z AO1_L_S_OW0 B_IH1_N AH0 M_EH1_M_B_ER0 AH1_V DH_AH0 Board AH1_V Directors AH1_V DH_AH0 Swiss R_IY2_IH0_N_SH_UH1_R_AH0_N_S G_R_UW1_P Swiss Re    Reinhardt S_T_AH1_D_IY0_D F_AA1_R_M_AH0_S_IY0 AE1_T DH_AH0 University AH1_V Saarland AH0_N_D G_R_AE1_JH_UW0_EY2_T_IH0_D IH0_N 1982 W_IH1_DH AH0 D_AA1_K_T_ER0_AH0_T He S_T_AA1_R_T_AH0_D HH_IH1_Z K_ER0_IH1_R IH0_N 1982 W_IH1_DH Sandoz    HH_UW1 M_ER1_JH_D W_IH1_DH Ciba Geigy IH0_N 1996 T_UW1 F_AO1_R_M Novartis At Sandoz    HH_IY1 W_ER1_K_T IH0_N R_IY0_S_ER1_CH AH0_N_D D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AH0_N_D B_IH0_K_EY1_M HH_EH1_D AH1_V D_IH0_V_EH1_L_AH0_P_M_AH0_N_T IH0_N 1994 Following DH_AH0 M_ER1_JH_ER0 IH1_N_T_UW0 Novartis    Reinhardt W_AA1_Z R_IY0_S_P_AA1_N_S_AH0_B_AH0_L F_AO1_R P_R_IY0_K_L_IH1_N_IH0_K_AH0_L D_IH0_V_EH1_L_AH0_P_M_AH0_N_T TH_R_UW0_AW1_T DH_AH0 G_R_UW1_P AH0_N_D L_EY1_T_ER0 F_AO1_R DH_AH0 IH0_N_T_AY1_ER0 D_R_AH1_G D_IH0_V_EH1_L_AH0_P_M_AH0_N_T In 2008    HH_IY1 B_IH0_K_EY1_M Chief Operating Officer AH1_V Novartis    From 2000 T_UW1 2010 Reinhardt W_AA1_Z President AH1_V DH_AH0 Board AH1_V Trustees AH1_V DH_AH0 Genomics Institute AH1_V DH_AH0 Novartis Research Foundation IH0_N DH_AH0 United States From 2010 T_UW1 2012    HH_IY1 W_AA1_Z Chairman AH1_V DH_AH0 Board AH1_V Management AH1_V Bayer HealthCare AG AH0_N_D Chairman AH1_V DH_AH0 Bayer HealthCare Executive Committee    Reinhardt IH1_Z M_EH1_R_IY0_D AH0_N_D F_AA1_DH_ER0 AH1_V T_UW1 CH_IH1_L_D_R_AH0_N He L_IH1_V_Z    S_IH1_N_S DH_AH0 K_AH0_M_P_L_IY1_SH_AH0_N AH1_V HH_IH1_Z S_T_AH1_D_IY0_Z    IH0_N Germany N_IH1_R Freiburg IH1_M Breisgau